000 01140 a2200325 4500
005 20250517153531.0
264 0 _c20171218
008 201712s 0 0 eng d
022 _a1538-2990
024 7 _a10.1016/j.amjms.2016.08.012
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIlias, Ioannis
245 0 0 _aGlossodynia After Osteoporosis Treatment.
_h[electronic resource]
260 _bThe American journal of the medical sciences
_cMay 2017
300 _a502-503 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAged
650 0 4 _aDenosumab
_xadverse effects
650 0 4 _aFemale
650 0 4 _aGlossalgia
_xchemically induced
650 0 4 _aHashimoto Disease
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aOsteoporosis
_xcomplications
650 0 4 _aThyroxine
_xtherapeutic use
700 1 _aVenaki, Evangelia
700 1 _aNikopoulou, Stamatina
700 1 _aKoch, Christian A
773 0 _tThe American journal of the medical sciences
_gvol. 353
_gno. 5
_gp. 502-503
856 4 0 _uhttps://doi.org/10.1016/j.amjms.2016.08.012
_zAvailable from publisher's website
999 _c27171484
_d27171484